• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈异常的患病率:博茨瓦纳围产期感染艾滋病毒的青年与老年妇女的比较。

The prevalence of cervical abnormalities: Comparison of youth with perinatally acquired HIV and older women in Botswana.

作者信息

Phologolo Thabo, Matshaba Mogomotsi, Mathuba Bathusi, Mokete Keboletse, Tshume Ontibile, Lowenthal Elizabeth

机构信息

Department of Family Medicine and Public Health, Faculty of Medicine, University of Botswana, Gaborone, Botswana.

Botswana-Baylor Children's Clinical Centre of Excellence, Gaborone, Botswana.

出版信息

South Afr J HIV Med. 2023 Mar 28;24(1):1455. doi: 10.4102/sajhivmed.v24i1.1455. eCollection 2023.

DOI:10.4102/sajhivmed.v24i1.1455
PMID:37064047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10091167/
Abstract

BACKGROUND

Cervical cancer burden and prevalence of precursor lesions is unknown among young women living with HIV in high prevalence settings. Current cervical cancer screening guidelines in resource-limited settings with high HIV prevalence typically exclude adolescents and young women. After observing two cases of advanced cervical cancer among young women with perinatally acquired HIV, a pilot screening programme was established in Botswana.

OBJECTIVES

To compare the prevalence of cervical abnormalities in young women with perinatally acquired HIV with women aged 30-49 years, regardless of HIV status.

METHOD

We conducted a cross-sectional study of 30-49-year-old women who had visual inspection with acetic acid screening through the Botswana public sector programme, and youth (aged 15-24 years) with perinatally acquired HIV, at a single referral site between 2016 and 2018. We describe the prevalence of cervical abnormalities in each group as well as the crude prevalence ratio.

RESULTS

The prevalence of cervical abnormalities in women 30-49 years of age was 10.9% (95% confidence interval [CI]: 10.4, 11.4), and 10.1% (95% CI: 4.7, 18.3) for youth. The crude prevalence ratio was 1.07 (95% CI: 0.58, 2.01).

CONCLUSION

Inclusion of youth living with HIV in cervical cancer screening services should be considered in settings with a high prevalence of HIV and cervical cancer.

摘要

背景

在艾滋病病毒高流行地区,感染艾滋病病毒的年轻女性的宫颈癌负担和癌前病变患病率尚不清楚。在艾滋病病毒高流行的资源有限地区,目前的宫颈癌筛查指南通常将青少年和年轻女性排除在外。在观察到两例围产期感染艾滋病病毒的年轻女性患晚期宫颈癌后,博茨瓦纳开展了一项试点筛查项目。

目的

比较围产期感染艾滋病病毒的年轻女性与30 - 49岁女性(无论艾滋病病毒感染状况如何)的宫颈异常患病率。

方法

2016年至2018年期间,我们在一个转诊点对通过博茨瓦纳公共部门项目接受醋酸目视检查筛查的30 - 49岁女性以及围产期感染艾滋病病毒的青年(15 - 24岁)进行了一项横断面研究。我们描述了每组宫颈异常的患病率以及粗患病率比。

结果

30 - 49岁女性的宫颈异常患病率为10.9%(95%置信区间[CI]:10.4, 11.4),青年的患病率为10.1%(95% CI:4.7, 18.3)。粗患病率比为1.07(95% CI:0.58, 2.01)。

结论

在艾滋病病毒和宫颈癌高流行地区,应考虑将感染艾滋病病毒的青年纳入宫颈癌筛查服务。

相似文献

1
The prevalence of cervical abnormalities: Comparison of youth with perinatally acquired HIV and older women in Botswana.宫颈异常的患病率:博茨瓦纳围产期感染艾滋病毒的青年与老年妇女的比较。
South Afr J HIV Med. 2023 Mar 28;24(1):1455. doi: 10.4102/sajhivmed.v24i1.1455. eCollection 2023.
2
Support for lowering cervical cancer screening age to 25 for women living with HIV: retrospective cross-sectional programmatic data from Botswana.支持将 HIV 感染者的宫颈癌筛查年龄降低至 25 岁:来自博茨瓦纳的回顾性横断面规划数据。
BMC Womens Health. 2022 Apr 2;22(1):100. doi: 10.1186/s12905-022-01680-7.
3
Cervical cancer prevention in HIV-infected women using the "see and treat" approach in Botswana.博茨瓦纳使用“见即治”方法预防感染艾滋病毒的妇女宫颈癌。
J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):308-13. doi: 10.1097/QAI.0b013e3182426227.
4
High-risk human papillomavirus prevalence in self-collected cervicovaginal specimens from human immunodeficiency virus (HIV)-negative women and women living with HIV living in Botswana.博茨瓦纳 HIV 阴性和 HIV 阳性女性的自我采集宫颈阴道标本中人乳头瘤病毒高危型的流行率。
PLoS One. 2020 Feb 13;15(2):e0229086. doi: 10.1371/journal.pone.0229086. eCollection 2020.
5
HIV infection is not associated with the initiation of curative treatment in women with cervical cancer in Botswana.在博茨瓦纳,HIV 感染与宫颈癌女性开始根治性治疗无关。
Cancer. 2019 May 15;125(10):1645-1653. doi: 10.1002/cncr.31972. Epub 2019 Feb 25.
6
Frequency of high-grade squamous cervical lesions among women over age 65 years living with HIV.65 岁以上 HIV 感染者中高级别宫颈鳞状上皮内病变的频率。
Am J Obstet Gynecol. 2021 Oct;225(4):411.e1-411.e7. doi: 10.1016/j.ajog.2021.04.253. Epub 2021 May 3.
7
Cervical cancer and precancerous cervical lesions detected using visual inspection with acetic acid at Livingstone Teaching Hospital.利文斯顿教学医院采用醋酸肉眼观察法检测出的宫颈癌和癌前宫颈病变。
Pan Afr Med J. 2021 Dec 17;40:235. doi: 10.11604/pamj.2021.40.235.32300. eCollection 2021.
8
Cervical pap screening cytological abnormalities among HIV-infected adolescents in the LEGACY cohort.遗产队列中感染艾滋病毒青少年的宫颈巴氏筛查细胞学异常情况。
J Pediatr Adolesc Gynecol. 2012 Feb;25(1):27-34. doi: 10.1016/j.jpag.2011.09.002. Epub 2011 Nov 16.
9
Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.在坦桑尼亚感染艾滋病毒和未感染艾滋病毒的女性中,醋酸目视检查和人乳头瘤病毒检测用于检测高级别宫颈病变的效能。
Int J Cancer. 2014 Aug 15;135(4):896-904. doi: 10.1002/ijc.28712. Epub 2014 Feb 4.
10
Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.布基纳法索和南非艾滋病毒 1 型感染者中宫颈癌筛查和筛查分流策略的诊断准确性:一项队列研究。
PLoS Med. 2021 Mar 4;18(3):e1003528. doi: 10.1371/journal.pmed.1003528. eCollection 2021 Mar.

引用本文的文献

1
High-risk human papillomavirus prevalence and serostatus in a cohort of cisgender women and people with a cervix living with perinatally acquired HIV.一组顺性别女性和患有围产期获得性艾滋病毒的宫颈疾病患者中的高危型人乳头瘤病毒流行率和血清状态
HIV Med. 2025 May;26(5):709-720. doi: 10.1111/hiv.70001. Epub 2025 Feb 25.
2
Human papillomavirus infection among adolescents living with HIV: a focus on prevention.青少年人类乳头瘤病毒感染:关注预防。
Curr Opin HIV AIDS. 2024 Nov 1;19(6):361-367. doi: 10.1097/COH.0000000000000868. Epub 2024 Jun 19.

本文引用的文献

1
Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer.人乳头瘤病毒疫苗对癌症的有效性和效力
Vaccines (Basel). 2021 Nov 30;9(12):1413. doi: 10.3390/vaccines9121413.
2
Low CD4 count and educational status predict abnormal cervical smears amongst HIV-positive women initiating antiretroviral therapy in South Africa.在南非开始接受抗逆转录病毒治疗的艾滋病毒阳性女性中,低CD4细胞计数和教育程度可预测宫颈涂片异常。
South Afr J HIV Med. 2020 Mar 30;21(1):1045. doi: 10.4102/sajhivmed.v21i1.1045. eCollection 2020.
3
Factors Related to Advanced Stage of Cancer Presentation in Botswana.与博茨瓦纳癌症晚期表现相关的因素。
J Glob Oncol. 2018 Dec;4:1-9. doi: 10.1200/JGO.18.00129.
4
Predictors of Locally Advanced Disease at Presentation and Clinical Outcomes Among Cervical Cancer Patients Admitted at a Tertiary Hospital in Botswana.博茨瓦纳一家三级医院收治的宫颈癌患者中局部晚期疾病的预测因素及临床结局。
Int J Gynecol Cancer. 2018 Jul;28(6):1218-1225. doi: 10.1097/IGC.0000000000001284.
5
Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis.主动监测下未经治疗的2级宫颈上皮内瘤变的临床病程:系统评价和荟萃分析
BMJ. 2018 Feb 27;360:k499. doi: 10.1136/bmj.k499.
6
Cancer in adolescents and young adults living with HIV.青少年和青年 HIV 感染者中的癌症。
Curr Opin HIV AIDS. 2018 May;13(3):196-203. doi: 10.1097/COH.0000000000000460.
7
Cervical cancer risk and impact of Pap-based screening in HIV-positive women on antiretroviral therapy in Johannesburg, South Africa.南非约翰内斯堡地区感染艾滋病毒女性的宫颈癌风险以及基于巴氏涂片检查的筛查对抗逆转录病毒治疗的影响。
Int J Cancer. 2017 Aug 1;141(3):488-496. doi: 10.1002/ijc.30749. Epub 2017 May 19.
8
Cervical cancer screening in rural South Africa among HIV-infected migrant farm workers and sex workers.南非农村地区感染艾滋病毒的流动农场工人和性工作者的宫颈癌筛查
Gynecol Oncol Rep. 2017 Jan 29;20:18-21. doi: 10.1016/j.gore.2016.12.011. eCollection 2017 May.
9
HIV Infection and Survival Among Women With Cervical Cancer.宫颈癌女性中的HIV感染与生存情况
J Clin Oncol. 2016 Nov 1;34(31):3749-3757. doi: 10.1200/JCO.2016.67.9613.
10
Host responses to infection with human papillomavirus.宿主对人乳头瘤病毒感染的反应。
Curr Probl Dermatol. 2014;45:58-74. doi: 10.1159/000355964. Epub 2014 Mar 13.